Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.

MLA

Friedberg, Scott, et al. “Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 21, no. 7, July 2023, p. 1913. EBSCOhost, https://doi.org/10.1016/j.cgh.2023.03.001.

APA

Friedberg, S., Choi, D., Hunold, T., Choi, N. K., Garcia, N. M., Picker, E. A., Cohen, N. A., Cohen, R. D., Dalal, S. R., Pekow, J., Sakuraba, A., Krugliak Cleveland, N., & Rubin, D. T. (2023). Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 21(7), 1913. https://doi.org/10.1016/j.cgh.2023.03.001

Chicago

Friedberg, Scott, David Choi, Thomas Hunold, Natalie K Choi, Nicole M Garcia, Emma A Picker, Nathaniel A Cohen, et al. 2023. “Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (7): 1913. doi:10.1016/j.cgh.2023.03.001.